News & Updates

Doubling the routine aspirin dose used for pre-eclampsia prevention appears to help lower the risk of developing pre-eclampsia with severe features among high-risk pregnant women with obesity, according to the results of the open-label ASPREO trial.

Adding metformin to insulin neither lowers the risk of developing preterm pre-eclampsia nor improves the risk markers of cardiovascular disease in pregnant women who have received a diagnosis of diabetes early in pregnancy or have existing type 2 diabetes mellitus, according to a study.

Testosterone treatment does not help lower the incidence of clinical fractures in middle-aged and older men with hypogonadism, according to a study.

Treatment with semaglutide induces weight loss in Asians with overweight or obesity, regardless of the presence of type 2 diabetes, according to the phase IIIa STEP 7 study.

An artificial intelligence (AI)-based model, dubbed AI-Thyroid, for the diagnosis of thyroid cancer demonstrates its utility in improving diagnostic performance and interobserver agreement, which could be helpful in less-experienced physicians, reports a study.

The glucagon/GLP-1 receptor dual agonist survodutide appears to be safe and induce weight loss in individuals with obesity, according to data from a phase II dose-finding trial.